Treat Sexually Transmitted Infections Early
Early treatment prevents spreading the infection to others. If you are sexually active, it is important to get tested regularly at your healthcare provider, an urgent care, or other local clinic that specializes in treating these infections. Testing is the only way to know for sure if you have an STI.
Visby Medical Will Exhibit at the APHL 2022 Annual Conference
Visby Medical Will Exhibit at the APHL 2022 Annual Conference, a hybrid event for the public health laboratory (PHL) community.
Visby Medical to Exhibit at the UCA/CUCM 2022 Annual Convention
Visby Medical will exhibit at the UCA/CUCM 2022 Annual Convention. UCA is a trade and professional association in urgent care with more than 3,700 member centers representing urgent care clinical and business professionals from the United States and abroad.
Visby Medical to Exhibit at the NAACOS Spring 2022 Conference
Visit our booth on the show floor of the NAACOS Spring 2022 Conference to learn about our revolutionary palm-sized PCR for three critical sexual health targets — chlamydia, gonorrhea, and trichomonas.
Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results
The Body Agency Collective, Visby Medical, Inc. and CCHCI observe National STD Awareness Month with women’s health initiative on US-Mexico border.
CCHCI among first healthcare providers in the nation to adopt new handheld PCR technology to detect gonorrhea, chlamydia and trichomoniasis in a single visit.
Visby Medical to Exhibit at the ACOG Annual Clinical and Scientific Meeting
Visby Medical will be exhibiting at the ACOG Annual Clinical and Scientific Meeting (ACSM). ACSM has long been a gathering of the leading women’s health care experts.
Urgent Care For Children Collaborates With Visby Medical To Provide New Gold Standard Diagnostic For Sexually Transmitted Infections
Pediatric urgent care provider among first in the US to adopt new point-of-care STI diagnostic device in adolescents and young adults
Visby Medical Executes Contract Option with BARDA for $25.5M to Develop Rapid Flu-COVID PCR Test Designed for At-Home Use
Visby Medical today announced that it has received an additional $25.5M in federal funding to develop and validate an at-home combination Flu-Covid test from the Biomedical Advanced Research and Development Authority (BARDA)
Visby Medical Raises over $100 Million in Series E Financing
Investment will accelerate the development of revolutionary rapid, single-use PCR diagnostic technology for home use
Visby Medical to Present at the J.P. Morgan 40th Annual Healthcare Conference
Visby Medical™ announced that it will make its debut appearance at the 40th Annual J.P. Morgan Healthcare Conference.
